Sagimet Biosciences Ratios (2022-2026) | SGMT

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Ratios	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Profitability
EBT Margin (Quarter)						-317.85%
EBIT Margin (Quarter)						-372.60%
EBITDA Margin (Quarter)						-317.65%
Operating Margin (Quarter)						-372.60%
Net Margin (Quarter)						-317.85%
FCF Margin (Quarter)						-193.95%
Efficiency
Assets Average (Quarter)						62.21M	99.82M	145.62M	191.77M	181.90M	167.52M	153.22M	141.79M	132.90M	122.44M	112.12M
Equity Average (Quarter)		-176.99M	-183.75M	-189.82M	-195.56M	-50.27M	94.47M	140.54M	186.66M	176.99M	163.24M	147.40M	134.58M	124.71M	115.32M	106.92M
Invested Capital (Quarter)	-173.42M	-180.55M	-186.95M	-192.70M	-198.41M	97.88M	91.06M	190.02M	183.29M	170.68M	155.81M	138.99M	130.16M	119.25M	111.38M	102.46M
Leverage & Solvency
Equity Ratio (Quarter)			-5.66		-9.23	0.95	0.94	0.98	0.97	0.98	0.97	0.95	0.95	0.93	0.96	0.95
Valuation
Enterprise Value (Quarter)			-32.34M		-18.51M	-101.80M	-94.90M	-193.71M	-166.37M	-152.49M	-151.25M	-144.57M	-125.41M	-116.69M	-113.12M	-104.54M
Return Ratios
Return on Sales (Quarter)						-0.03%
Return on Capital Employed (Quarter)						-50.14%	-32.64%				-33.39%		-49.71%	-51.97%	-48.48%	-45.62%
Return on Assets (Quarter)						0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (Quarter)				0.00%	0.00%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%